Navigation Links
Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights
Date:11/1/2007

28,119 26,813

Interest income and

other, net 864 1,189 2,855 3,402

Net income (loss) (2) $12,307 $(6,259) $(1,372) (19,142)

Net loss per share,

basic and diluted (2) $0.43 $(0.22) $(0.05) $(0.67)

Share used in

calculating net loss

per share, basic and

diluted 28,651 28,562 28,637 28,489

(1) Includes $77 and ($1,897) as additional (reduction in) research and

development expense, which represents an estimate of the net payable

due to (reimbursement by) Novartis of ANA975 research and development

costs for the three months ended September 30, 2007 and 2006,

respectively. Includes ($514) and ($3,423) as an offset in research

and development expense, which represents an estimate of the net

reimbursement by Novartis of ANA975 research and development costs for

the nine months ended September 30, 2007 and 2006, respectively.

(2) Includes non-cash operating expenses of $1,392 and $2,010 determined

in accordance with Statement of Financial Accounts Standards No.

123(R), "Share-Based Payment" (SFAS No. 123(R)) or approximately $0.05

and $0.07 effect on basic and diluted net income (loss) per common

share for the three months ended September 30, 2007 and 2006,

respectively. Research and development expense and general and

administrative expense includes $969 and $423 of non-cash operating

expenses determined in accordance with SFAS No. 123(R) for the three

months ended September 30, 2007. Includes non-cash operating expenses

of $3,502 and $4,951 determined in accordance with Financial Accounts

Standards Board Statement 123(R), "Share-Based Payment" or

approximately $0.12 and $0.17 effect on basic and diluted net l
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
4. Sonic Foundry reports GAAP loss as Q2 revenues rise
5. Fiserv reports $113.5 million in Q1 profit
6. Third Wave reports net loss of $18.9M for 2006
7. Musicnotes reports 45 percent growth in 2006
8. Sonic Foundry reports net loss, higher revenue
9. Sonic Foundry reports first cash-positive quarter
10. Merge Healthcare reports $10.8M net loss in Q3
11. Third Wave reports $5.2M third quarter loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... (PRWEB) February 26, 2015 The ... -12, at the Ernest N. Morial Convention Center ... (count as of February 19, 2015) displaying products ... industrial, academic, and government labs. The Exposition will ... but not limited to, analytical chemistry; drug discovery; ...
(Date:2/26/2015)... MD (PRWEB) February 26, 2015 RURO, ... provider, released FreezerPro® version 6.2 – the latest update ... FreezerPro® reputation is that of a quick and easy ... work. With the latest version, RURO engineering has enhanced ... import to move large amounts of sample records. ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 Regis Technologies ... the development of oncology drug substances. , Regis Technologies ... of their new Potent Compound Suite (PCS) for 2015. ... 36,000 square foot, cGMP facility in Morton Grove, Illinois. ... manufacturing of potent compounds up to about one kilogram ...
(Date:2/26/2015)... 2015  Epic Sciences announced today that President and ... the 35th Annual Cowen and Company Health Care Conference ... Room, 3rd Floor. The conference will be held at ... Epic is developing diagnostic tests of high clinical ... changes that occur during the course of cancer treatments. ...
Breaking Biology Technology:Pittcon 2015 Announces Exposition Highlights 2RURO Releases FreezerPro® version 6.2 2Regis Extends cGMP Services to Oncology Market 2Epic Sciences to Present at 35th Annual Cowen and Company Health Care Conference 2
... MUNDELEIN, Ill., April 22 Sysmex America, ... Medical Center,s (Canton, OH),beta studies for its ... solution, which combines the Sysmex HST-N hematology,automation ... II TURBO,Link, enables on-demand, automated diabetes testing ...
... Full Control of Belinostat, Consolidating ... Global Rights for the Product TopoTarget Acquires ... - Deal Covers a Payment of USD 26 million (DKK 122.8 ... - Webcast Conference Call to be Held 2pm CET, TopoTarget ...
... DC A new analysis by the Project ... are investing nearly twice as much as the ... potential risks of nanotechnology. The analysis also highlights ... risk-research investment figures for the U.S. , ...
Cached Biology Technology:Mercy Medical Center Completes Beta Studies for Integrated Hematology and Automated Diabetes Testing Solution 2Mercy Medical Center Completes Beta Studies for Integrated Hematology and Automated Diabetes Testing Solution 3Mercy Medical Center Completes Beta Studies for Integrated Hematology and Automated Diabetes Testing Solution 4TopoTarget Successfully Buys Back Full Control of Belinostat 2TopoTarget Successfully Buys Back Full Control of Belinostat 3TopoTarget Successfully Buys Back Full Control of Belinostat 4TopoTarget Successfully Buys Back Full Control of Belinostat 5TopoTarget Successfully Buys Back Full Control of Belinostat 6TopoTarget Successfully Buys Back Full Control of Belinostat 7Europe spends nearly twice as much as US on nanotech risk research 2
(Date:2/5/2015)... Jan. 27, 2015   Marvin Test ... deployed, innovative test solutions for military, aerospace, ... of its TS-323 GENASYS Test Platform ... (LMSSC). GENASYS is a high-performance PXI-based system ... applications that require performance functional testing. GENASYS ...
(Date:2/5/2015)... 30, 2015  It is gratifying to see that ... for genomic science as a means to better understand ... treatment.  I was honored to participate in today,s White ... program. Since the 1980s my teams ... the first sequenced genome of a free living organism, ...
(Date:1/22/2015)... , Jan. 13, 2015 /PRNewswire/ - Today, FindBiometrics, the leading ... the launch of its new website design. "When ... its infancy", says Peter O,Neill , founder and CEO ... the industry needs involvement from the key players on a ...
Breaking Biology News(10 mins):Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2
... today that it will receive a tuberculosis (TB) biomarkers ... Challenges in Global Health program, an initiative that seeks ... can radically improve health in the developing world. Urs ... SomaLogic, will pursue an innovative research project to identify ...
... dive behaviour and search for food of southern elephant seals. ... Research in the Helmholtz Association cooperating in a joint study ... Cape Town have discovered that the seals dive deeper for ... to the migration of prey to greater depths and now ...
... 2012 Attention-deficit/hyperactivity disorder (ADHD) affects 5-9% of youth ... methylphenidate and amphetamine products. A recent safety communication from ... patients undergoing ADHD treatment be monitored for changes in ... concern over the risks of stimulant use in youth, ...
Cached Biology News:SomaLogic Inc. receives Grand Challenges tuberculosis biomarkers grant 2Ocean warming causes elephant seals to dive deeper 2Ocean warming causes elephant seals to dive deeper 3Stimulant treatment for ADHD not associated with increased risk of cardiac events in youth 2
... UltraVIEW system and want to enjoy the sensitivity ... No problem. Our experienced team can give ... lasers, Sutter filter wheel, Piezo Stage etc. and ... precision controller unit and workstation... for a lot ...
... Dyad instrument is the most advanced thermal ... world-class thermal performance, the Dyad also boasts ... as point-and-click navigation via touch pad or ... easily and economically expanded to a four-bay ...
...
...
Biology Products: